With nearly 80 Selexis-generated research cell banks being used for commercial manufacturing in clinical trials and two marketed products in oncology and inflammation, we are extremely proud of what has been achieved with our partners.
The Selexis SUREtechnology Platform™ has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.
Selexis continues to seek strategic alliances and out-licensing opportunities within the biopharmaceutical industry. For more information about partnerships, licensing, internal development capabilities, or other business development opportunities, please contact Selexis.
Connect with the leaders in cell line development. From difficult-to-express to novel proteins, Selexis is your partner of choice.